Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD

August 16, 2011 updated by: Maastricht University Medical Center

The Effects of Exercise on the Metabolic Fate of Branched Chain Amino Acids in Relation to Aging and Chronic Disease.

Studies on resting human muscle show that ingestion of the branched-chain amino acids (BCAA): leucine, valine and isoleucine have an anabolic effect on muscle protein metabolism. However, the effects of BCAA intake on protein metabolism during exercise are less clear. When BCAA were supplied as single amino acids, without other amino acids and/or carbohydrates, no effects were observed on protein kinetics. On the other hand, ingestion of BCAA during running appeared to reduce the catabolic effect of running on muscle protein metabolism. These experiments were all performed with mixtures of the BCAA with or without carbohydrates but not in the form of complete meals with food protein as a basis. Therefore, it is still unknown whether a protein meal, containing a substantial amount of BCAA is beneficial during exercise by inducing an anabolic effect.

Whey and Casein protein contain a substantial amount of BCAA in contrast to Soy protein. Therefore, it is hypothesized that milk-based proteins are a better and more physiological source of BCAA during exercise and will lead to more protein anabolism. Most of the available studies have been carried out in young and fit humans but there are hardly any data are available in the increasing population of the elderly. Therefore it is still unknown whether a BCAA rich protein meal can enhance the anabolic effect of exercise in older individuals.

Besides sarcopenia, a substantial part of the elderly is suffering from a chronic systemic disease such as chronic obstructive pulmonary disease (COPD). COPD represents an important health care problem. COPD is the fourth leading cause of death and will be the third leading cause worldwide in 2020. Besides the local impairment, COPD is a chronic wasting disease, associated with alterations in intermediary metabolism. Substantial disturbances have been found in BCAA (and related) metabolism in these patients at rest and during exercise. It might therefore be of clinical relevance to study the metabolic effects of BCAA rich protein meals in patients with COPD at rest and during exercise.

Study Overview

Detailed Description

In this study we investigate whether milk based protein sources of BCAA (casein and whey proteins) are superior to soy protein in the stimulation of protein anabolism before, during and after cycle exercise in COPD and healthy elderly and young subjects, and whether adding BCAA to soy protein will increase protein anabolism in these subjects.

To investigate Leucine, Isoleucine and Valine metabolism during and after exercise in COPD and healthy subjects

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Irreversible chronic airflow limitation (FEV1 <70% of predicted)
  • Clinically stable condition

Exclusion Criteria:

  • Oxygen supplementation
  • Respiratory tract infection or exacerbation of his disease at least 4 weeks prior to the study
  • Oral corticosteroids as maintenance medication
  • Other concomitant metabolic disease (ie malignancy, cardiac failure, recent surgery, severe endocrine, hepatic or renal disorder)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Caseinate protein intake
18 mg protein/kg body weight caseinate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
18 mg protein/kg body weight caseinate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
Other Names:
  • casein
EXPERIMENTAL: Whey protein isolate intake
18 mg protein/kg body weight whey protein isolate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
18 mg protein/kg body weight whey protein isolate and 46 mg maltodextrin / kg body weight per 20 min sip feeding
Other Names:
  • Whey
EXPERIMENTAL: Soy protein intake
18 mg protein/kg body weight soy and 46 mg maltodextrin / kg body weight per 20 min sip feeding
18 mg protein/kg body weight soy and 46 mg maltodextrin / kg body weight per 20 min sip feeding
EXPERIMENTAL: soy+BCAA protein intake
18 mg protein/kg body weight soy+BCAA and 46 mg maltodextrin / kg body weight per 20 min sip feeding
18 mg protein/kg body weight soy+BCAA and 46 mg maltodextrin / kg body weight per 20 min sip feeding

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Net whole body protein synthesis
Time Frame: 6 hours
Net whole body protein synthesis during protein feeding and the response to a 20 min cycle exercise bout
6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in whole body protein synthesis rate
Time Frame: 6 hours
Whole body protein synthesis rate during protein feeding and the response to 20 min cycle exercise bout
6 hours
Change in Leucine turnover
Time Frame: 6 hours
Leucine turnover during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Change in Isoleucine turnover
Time Frame: 6 hours
Isoleucine turnover during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Change in Valine turnover
Time Frame: 6 hours
Valine turnover during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Change in plasma lactate concentration
Time Frame: 6 hours
Plasma lactate during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Change in NH3 concentration
Time Frame: 6 hours
Plasma NH3 during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Change in plasma amino acids concentrations
Time Frame: 6 hours
Plasma amino acid concentrations during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Splanchnic extraction of amino acids during protein feeding
Time Frame: 6 hours
Splanchnic extraction of amino acids during protein feeding and the response to a 20 min cycle exercise bout
6 hours
Change in whole body protein breakdown rate
Time Frame: 6 hours
Whole body protein breakdown rate during protein feeding and the response to cycle exercise
6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2002

Primary Completion (ACTUAL)

December 1, 2003

Study Completion (ACTUAL)

December 1, 2004

Study Registration Dates

First Submitted

August 9, 2011

First Submitted That Met QC Criteria

August 16, 2011

First Posted (ESTIMATE)

August 17, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

August 17, 2011

Last Update Submitted That Met QC Criteria

August 16, 2011

Last Verified

August 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Caseinate

3
Subscribe